Cargando...
Hyperammonemic encephalopathy in a patient receiving fluorouracil/oxaliplatin chemotherapy
Hyperammonemia is a rare adverse effect of 5‐fluorouracil (5‐FU) therapy, but can be very serious, even fatal. Physicians must be aware that hyperammonemic encephalopathy sometimes develops as an adverse event after 5‐FU therapy.
Gardado en:
| Publicado en: | Clin Case Rep |
|---|---|
| Main Authors: | , , , , , , , |
| Formato: | Artigo |
| Idioma: | Inglês |
| Publicado: |
John Wiley and Sons Inc.
2018
|
| Assuntos: | |
| Acceso en liña: | https://ncbi.nlm.nih.gov/pmc/articles/PMC5889268/ https://ncbi.nlm.nih.gov/pubmed/29636922 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1002/ccr3.1422 |
| Tags: |
Engadir etiqueta
Sen Etiquetas, Sexa o primeiro en etiquetar este rexistro!
|